JPY 2999.0
(-0.86%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 811.47 Million | 1.63 Billion | 609.81 Million | 1.83 Billion | 717.69 Million | 2.05 Billion |
Net Income | 1.02 Billion | 1.12 Billion | 808.85 Million | 979.28 Million | 1.08 Billion | 1.32 Billion |
Depreciation & Amortization | 197.24 Million | 232 Million | 236.96 Million | 241.94 Million | 261.15 Million | 307.23 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -523.45 Million | 530.17 Million | -219.82 Million | 957.49 Million | -272.57 Million | 939.31 Million |
Other non-cash items | 1.15 Billion | -252.84 Million | -216.17 Million | -341.11 Million | -352.32 Million | -517.01 Million |
Investing Cash Flow | -1.1 Billion | -876.1 Million | 194.54 Million | -1.01 Billion | -242.05 Million | -1.28 Billion |
Investments in PPE | -309.58 Million | -3.61 Billion | -496.78 Million | -171.74 Million | -535.43 Million | -341.56 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -4.8 Billion | -5.8 Billion | -6.41 Billion | -6.3 Billion | -4.37 Billion | -2.2 Billion |
Sales/Maturities of investments | 4.3 Billion | 6.5 Billion | 7.1 Billion | 5.46 Billion | 2.7 Billion | 1.3 Billion |
Other Investing Activities | -295.58 Million | 2.04 Billion | 2.63 Million | 2.87 Million | 1.96 Billion | -30.8 Million |
Financing Cash Flow | -507.43 Million | 313.69 Million | -357.33 Million | -502.06 Million | 37.19 Million | -596.04 Million |
Debt repayment | -142.8 Million | -435.7 Million | - | - | -400 Million | - |
Dividends payments | -266.03 Million | -250.55 Million | -357.33 Million | -360.41 Million | -362.68 Million | -474.93 Million |
Common Stock Repurchased | -98.6 Million | -51 Thousand | - | -141.64 Million | -114 Thousand | -121.11 Million |
Common Stock Issuance | - | 1 Billion | - | - | -400 Million | - |
Other Financing Activities | -1000.00 | -2000.00 | - | -1 Million | 1.19 Billion | -1 Million |
Accounts receivables | -911.48 Million | 1.16 Billion | -609.62 Million | 1.75 Billion | -832.53 Million | 1.25 Billion |
Accounts payables | 515.3 Million | -404.7 Million | 199.45 Million | -830.59 Million | 387.55 Million | -490.1 Million |
Inventory | -247.84 Million | -139.66 Million | 215.97 Million | 56.08 Million | 124.36 Million | 204.84 Million |
Other working capital | 120.57 Million | -86.27 Million | -25.62 Million | -27.89 Million | 48.04 Million | -26.25 Million |
Cash at beginning of period | 5.62 Billion | 4.55 Billion | 4.1 Billion | 3.79 Billion | 3.27 Billion | 3.1 Billion |
Cash at end of period | 4.82 Billion | 5.62 Billion | 4.55 Billion | 4.1 Billion | 3.79 Billion | 3.27 Billion |
Capital Expenditure | -309.58 Million | -3.61 Billion | -496.78 Million | -171.74 Million | -535.43 Million | -341.56 Million |
Effect of forex changes on cash | - | - | 1000.00 | -1000.00 | 1000.00 | -1000.00 |
Net cash flow / Change in cash | -803.52 Million | 1.07 Billion | 447.03 Million | 316.95 Million | 512.84 Million | 179.01 Million |
Free Cash Flow | 501.89 Million | -1.97 Billion | 113.03 Million | 1.66 Billion | 182.26 Million | 1.71 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 805 Million | 1.02 Billion | 139 Million | 267 Million | 288 Million | 326 Million |
Depreciation & Amortization | - | 197.24 Million | - | - | 45.33 Million | 41.52 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -523.45 Million | - | - | - | - |
Other non-cash items | -805 Million | 1.15 Billion | -139 Million | -267 Million | -288 Million | -326 Million |
Investing Cash Flow | - | -1.1 Billion | - | - | - | - |
Investments in PPE | - | -309.58 Million | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -4.8 Billion | - | - | - | - |
Sales/Maturities of investments | - | 4.3 Billion | - | - | - | - |
Other Investing Activities | - | -295.58 Million | - | - | - | - |
Financing Cash Flow | - | -507.43 Million | - | - | - | - |
Debt repayment | - | -142.8 Million | - | - | - | - |
Dividends payments | - | -266.03 Million | - | - | - | - |
Common Stock Repurchased | - | -98.6 Million | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -1000.00 | - | - | - | - |
Accounts receivables | - | -911.48 Million | - | - | - | - |
Accounts payables | - | 515.3 Million | - | - | - | - |
Inventory | - | -247.84 Million | - | - | - | - |
Other working capital | - | 120.57 Million | - | - | - | - |
Cash at beginning of period | - | 5.62 Billion | - | - | 4.77 Billion | 5.62 Billion |
Cash at end of period | - | 4.82 Billion | - | - | 4.72 Billion | 4.77 Billion |
Capital Expenditure | - | -309.58 Million | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -803.52 Million | - | - | -46.8 Million | -855.9 Million |
Free Cash Flow | - | 501.89 Million | - | - | 90.66 Million | 83.04 Million |
PTAIY
000681
MTAM
LODHA
CME
AMBUJACEM